Pulmonary Diseases Completed Phase 2 Trials for Aflibercept (DB08885)

Also known as: Chronic Disease Lung / Lung; Disease / Lung disorders / Lung disorder/disease / Pneumopathy / Pulmonary Disorders / Chronic Lung Disease / Lung Disorder / Lung Diseases / Chronic Lung Diseases / Lung Disease Chronic / Lung Disease / Pulmonary disorder / Disease, Pulmonary / Pulmonary Disease / Disorder lung / Respiratory system diseases (& lung diseases) / Disease of lung (disorder) / Lung disease NOS (disorder) / Calcification of lung / Lung disorder (NOS) / Lung disorder NOS / Disorder pulmonary / Chronic lung disease (disorder) / Chronic disease of respiratory system (disorder) / Chronic respiratory disease / Respiratory disease (chronic) NOS / Chronic respiratory disease NOS

IndicationStatusPhase
DBCOND0033751 (Pulmonary Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00284141Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung AdenocarcinomaTreatment